Scrip
US FDA panel rejects Roche/Novartis's Xolair for children
19 November 2009
Sue Sutter
The US
FDA's pulmonary-allergy drugs advisory panel has voted against broadening use of
Roche (formerly
Genentech)/
Novartis's humanised monoclonal antibody Xolair (omalizumab) to children with asthma.
The agency's experts voted 10 to four that safety and efficacy data do not provide substantial...
Please Login to read the full article.
19 November 2009
Sue Sutter
The agency's experts voted 10 to four that safety and efficacy data do not provide substantial...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
